SOUMYA SINHA ROY

Dr. SOUMYA SINHA ROY

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2014 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
TATanvir Ahmad
Tanvir Ahmad
SMShravani Mukherjee
Shravani Mukherjee
BPBijay Pattnaik
Bijay Pattnaik
MKManish Kumar
Manish Kumar
SSSuchita Singh
Suchita Singh
AAAnurag Agrawal
Anurag Agrawal

17 January 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TATanvir Ahmad
Tanvir Ahmad
KAK Aggarwal
K Aggarwal
BPB Pattnaik
B Pattnaik
SMS Mukherjee
S Mukherjee
TSTavpritesh Sethi
Tavpritesh Sethi
AAA Agrawal
A Agrawal
Dynamic variations in mitochondrial shape have been related to function. However, tools to automatically classify and enumerate mitochondrial shapes are lacking, as are systematic studies exploring the relationship of such shapes to mitochondrial stress. Here we show that during increased generation of mitochondrial reactive oxygen species (mtROS), mitochondria change their shape from tubular to donut or blob forms, which can be computationally quantified. Imaging of cells treated with rotenone or antimycin, showed time and dose-dependent conversion of tubular forms to donut-shaped mitochondria followed by appearance of blob forms. Time-lapse images showed reversible transitions from tubular to donut shapes and unidirectional transitions between donut and blob shapes. Blobs were the predominant sources of mtROS and appeared to be related to mitochondrial-calcium influx. Mitochondrial shape change could be prevented by either pretreatment with antioxidants like N-acetyl cysteine or inhibition of the mitochondrial calcium uniporter. This work represents a novel approach towards relating mitochondrial shape to function, through integration of cellular markers and a novel shape classification algorithm.

9 October 2009 in EMBO Reports
Verified
Journal Article
Open access
PDF file
SRSOUMYA SINHA ROY
SOUMYA SINHA ROY
AEAmy M Ehrlich
Amy M Ehrlich
WCWilliam J Craigen
William J Craigen
GHGyörgy Hajnóczky
György Hajnóczky
Truncated BID (tBID), a proapoptotic BCL2 family protein, induces BAK/BAX‐dependent release of cytochrome c and other mitochondrial intermembrane proteins to the cytosol to induce apoptosis. The voltage‐dependent anion channels (VDACs) are the primary gates for solutes across the outer mitochondrial membrane (OMM); however, their role in apoptotic OMM permeabilization remains controversial. Here, we report that VDAC2−/− (V2−/−) mouse embryonic fibroblasts (MEFs) are virtually insensitive to tBID‐induced OMM permeabilization and apoptosis, whereas VDAC1−/−, VDAC3−/− and VDAC1−/−/VDAC3−/− MEFs respond normally to tBID. V2−/− MEFs regain tBID sensitivity after VDAC2 expression. Furthermore, V2−/− MEFs are deficient in mitochondrial BAK despite normal tBID–mitochondrial binding and BAX/BAK expression. tBID sensitivity of BAK−/− MEFs is also reduced, although not to the same extent as V2−/− MEFs, which might result from their strong overexpression of BAX. Indeed, addition of recombinant BAX also sensitized V2−/− MEFs to tBID. Thus, VDAC2 acts as a crucial component in mitochondrial apoptosis by allowing the mitochondrial recruitment of BAK, thereby controlling tBID‐induced OMM permeabilization and cell death. There is a Literature Report (December 2009) associated with this Scientific Report.

1 February 2009 in Molecular Cell
Verified
Journal Article
Closed access
SRSOUMYA SINHA ROY
SOUMYA SINHA ROY
MMMuniswamy Madesh
Muniswamy Madesh
EDErika Davies
Erika Davies
BABruno Antonsson
Bruno Antonsson
NDNika Danial
Nika Danial
GHGyörgy Hajnóczky
György Hajnóczky

5 March 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CGCecilia Garcia-Perez
Cecilia Garcia-Perez
SRSOUMYA SINHA ROY
SOUMYA SINHA ROY
SNShamim Naghdi
Shamim Naghdi
XLXuena Lin
Xuena Lin
EDErika Davies
Erika Davies
GHGyörgy Hajnóczky
György Hajnóczky
Bid-induced mitochondrial membrane permeabilization and cytochrome c release are central to apoptosis. It remains a mystery how tiny amounts of Bid synchronize the function of a large number of discrete organelles, particularly in mitochondria-rich cells. Looking at cell populations, the rate and lag time of the Bid-induced permeabilization are dose-dependent, but even very low doses lead eventually to complete cytochrome c release. By contrast, individual mitochondria display relatively rapid and uniform kinetics, indicating that the dose dependence seen in populations is due to a spreading of individual events in time. We report that Bid-induced permeabilization and cytochrome c release regularly demonstrate a wave-like pattern, propagating through a cell at a constant velocity without dissipation. Such waves do not depend on caspase activation or permeability transition pore opening. However, reactive oxygen species (ROS) scavengers suppressed the coordination of cytochrome c release and also inhibited Bid-induced cell death, whereas both superoxide and hydrogen peroxide sensitized mitochondria to Bid-induced permeabilization. Thus, Bid engages a ROS-dependent, local intermitochondrial potentiation mechanism that amplifies the apoptotic signal as a wave.

23 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
IFImam Faizan
Imam Faizan
RCRituparna Chaudhuri
Rituparna Chaudhuri
SSShakti Sagar
Shakti Sagar
SASarah Albogami
Sarah Albogami
NCNisha Chaudhary
Nisha Chaudhary
TATanvir Ahmad
Tanvir Ahmad
Circulating cell-free mitochondrial DNA (cf-mtDNA) has been found in the plasma of severely ill COVID-19 patients and is now known as a strong predictor of mortality. However, the underlying mechanism of mtDNA release is unexplored. Here, we show a novel mechanism of SARS-CoV-2-mediated pro-inflammatory/pro-apoptotic mtDNA release and a rational therapeutic stem cell-based approach to mitigate these effects. We systematically screened the effects of 29 SARS-CoV-2 proteins on mitochondrial damage and cell death and found that NSP4 and ORF9b caused extensive mitochondrial structural changes, outer membrane macropore formation, and the release of inner membrane vesicles loaded with mtDNA. The macropore-forming ability of NSP4 was mediated through its interaction with BCL2 antagonist/killer (BAK), whereas ORF9b was found to inhibit the anti-apoptotic member of the BCL2 family protein myeloid cell leukemia-1 (MCL1) and induce inner membrane vesicle formation containing mtDNA. Knockdown of BAK and/or overexpression of MCL1 significantly reversed SARS-CoV-2-mediated mitochondrial damage. Therapeutically, we engineered human mesenchymal stem cells (MSCs) with a simultaneous knockdown of BAK and overexpression of MCL1 (MSCshBAK+MCL1) and named these cells IMAT-MSCs (intercellular mitochondrial transfer-assisted therapeutic MSCs). Upon co-culture with SARS-CoV-2-infected or NSP4/ORF9b-transduced airway epithelial cells, IMAT-MSCs displayed functional intercellular mitochondrial transfer (IMT) via tunneling nanotubes (TNTs). The mitochondrial donation by IMAT-MSCs attenuated the pro-inflammatory and pro-apoptotic mtDNA release from co-cultured epithelial cells. Our findings thus provide a new mechanistic basis for SARS-CoV-2-induced cell death and a novel therapeutic approach to engineering MSCs for the treatment of COVID-19.